Free provider profile

MARK TAN, M.D.

NPI 1083770580
Individual
Internal Medicine, Rheumatology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MARK TAN?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MARK TAN prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Actemra
  • Prolia
  • Rinvoq
  • Xeljanz Xr
  • Remicade

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

631-724-8900

Fax

631-724-8901

Practice address

222 MIDDLE COUNTRY ROAD SUITE 312, SMITHTOWN, NY, 11787

Registry updated
2011-07-27
NPI issued
2006-12-29
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

222 MIDDLE COUNTRY ROAD SUITE 312, SMITHTOWN, NY, 11787

631-724-8900

Single practice location

Enumerated 2006-12-29

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record last updated 15 years ago.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,327

Medicare patients

289

Part D drug cost

$3,082,792

Brand-name share

40.4%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Actemra (Tocilizumab)90$396,878
Rinvoq (Upadacitinib)46$288,833
Remicade (Infliximab)36$287,679
Xeljanz Xr (Tofacitinib Citrate)45$240,103
Cosentyx Sensoready (2 Pens) (Secukinumab)19$178,118
Humira (Adalimumab)13$167,065
Prolia (Denosumab)88$152,015
Otezla (Apremilast)22$141,219

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across NY — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.